Is this your organization?Claim your profile for free to personalize your presence and add a donate button. Learn more

Start Your Claim

Claiming and managing your profile is free. Enter any email you have access to. In the next step, we'll give you a small snippet to place on the organization's website to verify ownership.

Email address

We'll use this to process your claim and send important profile updates.

Need help? Contact us

: Verified by RoundPaper

FY 2023

Verified NonprofitLast Filed 2023EIN 20-1991334

Critical Path Institute

TUCSON, AZNTEE: H99Founded 2004Website

mission statement

International collaborations and novel tools to enable faster development of safe medical products

Share this profile

Total Revenue

$42.6M

FY 2023

Program Spending

80.5%

of total expenses

Known Funders

2019–2024 filings

Key Metrics (FY 2023)

The Numbers

$31.3M

Total Assets

$19.5M net

6.11 mo

Operating Reserves

FY 2023

+21%

Revenue Growth

YoY

176

Total Employees

FY 2023

Funding Track Record

Backed by 18 Institutional Funders

$9.8M raised across 46 grants · +$1.4M committed (2019–2024 filings)

Funder Geography

Funders across 11 states (2019–2024 filings)

Institutional Funding by Year

PaidCommittedBoth

Funder	Location	Total Awarded
Michael J Fox Foundation for Parkinsons Research	NEW YORK, NY	$3,543,137
Alzheimers Disease Data Initiative Inc	KIRKLAND, WA	$1,833,822
The Leona M and Harry B Helmsley	NEW YORK, NY	$1,460,723 +$1,300,223 committed
The Parent Project for Muscular Dystrophy Research Inc	HACKENSACK, NJ	$599,601
Jdrf International	NEW YORK, NY	$530,757
Bill & Melinda Gates Foundation	SEATTLE, WA	$490,052
National Philanthropic Trust	JENKINTOWN, PA	$485,892
Institute for Advanced Clinical Trials	ROCKVILLE, MD	$293,867
Friedreichs Ataxia Research Alliance Fara	SPRINGFIELD, VA	$214,550
The Transplantation Society	Montreal	$115,000

Total tracked: $9,837,588 across 46 grants · +$1,437,723 committed across 5 commitments (2019–2024 filings)

Totals reflect grants as reported on funder tax returns. Timing may not match recipient revenue: funder and recipient fiscal years often differ, and grants paid by a funder in one year may be recognized by the recipient in a different year.

Programs (FY 2023)

What They Do

$7.1M in expenses

Critical path for rare neurodegenerative diseases (CP-RND) - see schedule o

$6.1M in expenses

Rare disease cures accelerator-data and analytics platform (rdca-dap) - see schedule o

$3.3M in expenses

Cure drug repurposing collaboratory (CDRC) - see schedule o

$14.3M in expenses

Critical path institute also executes other projects and consortia in areas including therapeutics for the ataxias, polycystic kidney disorder, alzheimer's disease, parkinson's, TB, sickle cell disease, type 1 diabetes, duchenne muscular dystrophy, alpha-1 antitrypsin deficiency, lysosomal diseases, model informed drug development, patient-reported outcome, electronic clinical outcome assessment, rare disease clinical outcome assessment, transplant therapeutics, predictive safety testing, pediatrics, and others.

Financial History